0001209191-20-009878.txt : 20200218
0001209191-20-009878.hdr.sgml : 20200218
20200218072259
ACCESSION NUMBER: 0001209191-20-009878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200218
DATE AS OF CHANGE: 20200218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Drape Eric
CENTRAL INDEX KEY: 0001790905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 20623502
MAIL ADDRESS:
STREET 1: C/O TEVA, 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-14
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001790905
Drape Eric
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 BASEL STREET
PETACH TIKVA
L3
4951033
ISRAEL
0
1
0
0
Executive VP Global Operations
Ordinary Shares
2020-02-14
4
M
0
13090
A
33708
D
Ordinary Shares
2020-02-14
4
M
0
3926
A
37634
D
Ordinary Shares
2020-02-14
4
S
0
6262
12.1357
D
31372
D
Ordinary Shares
2020-02-14
4
S
0
1878
12.1357
D
29494
D
Restricted Share Units
2020-02-14
4
M
0
13090
0.00
D
Ordinary Shares
13090
0
D
Restricted Share Units
2020-02-14
4
M
0
3926
0.00
D
Ordinary Shares
3926
3926
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.12 to $12.16, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on February 14, 2020.
Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2020 and February 14, 2021.
Dov Bergwerk as attorney-in-fact for Eric Drape
2020-02-18